Semax (ACTH Fragment Peptide)
Semax Structure, Sequence and Physical Properties
Semax has the sequence H-Met-Glu-His-Phe-Pro-Gly-Pro-OH: seven residues, molecular weight 813.9 Da, formula C37H51N9O10S. It contains two prolines that constrain backbone conformation, a single oxidation-prone methionine, and no cysteine, so no disulfide chemistry applies.
Key facts
- Sequence
- H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
- Residues
- 7
- Molecular weight
- 813.9 Da
- Molecular formula
- C37H51N9O10S
- Prolines
- Two (positions 5 and 7)
- Methionine
- One (position 1) — oxidation-prone
- Cysteines
- None
- Aromatic residues
- Phe, His
Reading the sequence
In single-letter code the peptide is MEHFPGP: methionine, glutamate, histidine, phenylalanine, proline, glycine, proline. At 813.9 Da it is a genuinely small peptide — roughly a third the mass of MOTS-c and a fifth of semaglutide — which has consequences for both stability and analysis.
What the prolines do to the backbone
Proline is the only proteinogenic amino acid whose side chain closes back onto the backbone nitrogen. That ring removes the amide hydrogen and restricts rotation, so proline residues impose local conformational rigidity and interrupt regular secondary structure. Two prolines in a seven-residue peptide is a very high density, and the resulting constrained conformation is a large part of why Semax resists proteolysis.
Research material referenced
Semax 10mg — third-party HPLC tested
Why proline-rich sequences resist peptidases
Most proteolytic enzymes need to bind an extended backbone conformation at their active site. Proline prevents the backbone adopting that geometry in its vicinity, so bonds adjacent to proline are poor substrates for the majority of peptidases. This is a general principle, not something specific to Semax, and it is why proline-rich motifs appear repeatedly in stabilised peptide design.
The histidine and the pH question
Histidine's imidazole side chain has a pKa near 6, meaning its charge state changes across the physiological range and across common buffer conditions. For a seven-residue peptide with a single histidine, that one residue carries a meaningful share of the molecule's pH-dependent behaviour, which is relevant when solubility or chromatographic retention shifts unexpectedly between buffers.
The methionine is the handling liability
Methionine at position 1 is the most chemically vulnerable feature. Its thioether sulfur oxidises readily to the sulfoxide in the presence of dissolved oxygen, accelerated by light and temperature, adding 16 Da. On a mass spectrum a degraded sample shows a +16 satellite alongside the parent mass. With only one methionine, +32 is not expected — unlike MOTS-c, which has two.
No disulfide chemistry
There is no cysteine in the sequence, so intramolecular or intermolecular disulfide formation is impossible and no reducing agent is required in buffers. Combined with the small size and proline rigidity, Semax is chemically among the more straightforward research peptides to handle — the methionine being the one thing to respect.
Quick reference
| Property | Value |
|---|---|
| Sequence | MEHFPGP |
| Length | 7 residues |
| Molecular weight | 813.9 Da |
| Formula | C37H51N9O10S |
| CAS | 80714-61-0 |
| UNII | I5FAL2585H |
| PubChem CID | 9811102 |
Extended research context
The Semax (ACTH Fragment Peptide) deep dive
Deep dive: what the Pro-Gly-Pro extension actually accomplishes
Semax is built from a four-residue fragment of ACTH with Pro-Gly-Pro appended, and that appendix does two separate jobs at once. Proline is the only proteinogenic amino acid whose side chain bonds back to its own backbone nitrogen, forming a ring that removes the amide hydrogen and locks rotation. Proteolytic enzymes generally need an extended, rotatable backbone at their active site, so bonds near proline are poor substrates for most of them — which is why proline-rich motifs recur throughout stabilised peptide design. The second job is subtractive: Pro-Gly-Pro occupies the positions where ACTH carries Arg-Trp-Gly, and those are the residues contributing to the parent hormone's adrenal-stimulating activity. One substitution therefore buys protease resistance and removes an unwanted pharmacology, which is unusually economical design.
Deep dive: the naming point worth getting right
Semax is near-universally described as an ACTH(4-10) analogue, and peer-reviewed paper titles use that phrase. Structurally it is not quite that. ACTH residues 4 to 10 are Met-Glu-His-Phe-Arg-Trp-Gly; Semax is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues match and the last three are wholly different — replacement rather than modification. PubChem, indexing by structure rather than design lineage, records it as ACTH(4-7) plus Pro-Gly-Pro. Neither name is wrong, but the loose one obscures the fact that the substituted segment is precisely the functionally consequential part.
Deep dive: reading an unevenly distributed evidence base
Semax's roughly 231 indexed records split along an unusual line. Mechanistic work — BDNF and trkB expression in rat hippocampus, transcriptomics in focal cerebral ischaemia, neurotrophin dynamics across brain regions — appears in international journals in English and can be assessed directly. Clinical work is concentrated in Russian-language publications, principally the Korsakov Journal of Neurology and Psychiatry, indexed by translated title and often without accessible English full text, much of it predating current standards for pre-registration and reporting. The honest position is that this is evidence which is difficult to verify independently, which is a different thing from evidence that is absent, and a different thing again from evidence that is established.
Research applications
- ▸Neurotrophin expression research (BDNF, NGF, TrkB, TrkA)
- ▸Neuroprotection and cerebral ischaemia models
- ▸Study of proline-stabilised peptide design
- ▸Comparative work on ACTH fragments without steroidogenic activity
- ▸Transcriptomic profiling in rodent brain models
Handling checklist
- ✓Store lyophilised material cold, dry and protected from light
- ✓Expect methionine oxidation as the degradation route (+16 Da; only one Met, so not +32)
- ✓No reducing agent needed — the sequence contains no cysteine
- ✓Introduce diluent gently against the vial wall; swirl rather than shake
- ✓Aliquot to avoid repeated freeze-thaw cycles
- ✓Check whether a certificate reports net peptide content or gross salt weight
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Describing Semax as ACTH(4-10) without qualification
Fix: It shares only residues 4-7; Pro-Gly-Pro replaces Arg-Trp-Gly, and that replacement is the design's whole point.
✗ Treating Russian registration as equivalent to MHRA approval
Fix: Authorisations are jurisdictional and do not transfer. Semax has never been assessed by the MHRA, EMA or FDA.
✗ Reading a BDNF expression change as a demonstrated outcome
Fix: The studies measured gene and protein expression in rats. Expression is upstream of function and upstream again of any clinical claim.
✗ Assuming a named receptor exists
Fix: No primary receptor has been definitively established; the literature characterises downstream effects more confidently than the initiating event.
✗ Expecting ACTH-like adrenal effects
Fix: Semax does not stimulate adrenal steroidogenesis — the responsible residues were substituted out.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- What is Semax?
- Is Semax really an ACTH(4-10) analogue?
- How does Semax affect BDNF?
- What are glyprolines?
- Is Semax approved in the UK?
- How does Semax differ from Selank?
Frequently asked questions
- Why are there two prolines?
- They come from the Pro-Gly-Pro extension, which was added to confer protease resistance. Proline constrains the backbone in a way most peptidases cannot accommodate.
- Does Semax form disulfide bonds?
- No. There is no cysteine in the sequence.
- Why would a mass spectrum show +16 Da?
- Oxidation of the single methionine to the sulfoxide. With one methionine, expect +16 rather than +32.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · Semax (CID 9811102)pubchem.ncbi.nlm.nih.gov
- PubMedPubMed — Semax literaturepubmed.ncbi.nlm.nih.gov
- PubMedSemax, an analog of ACTH(4-10), regulates BDNF and trkB expression — Brain Res 2006 (PMID 16996037)pubmed.ncbi.nlm.nih.gov
- PubMedThe heptapeptide SEMAX stimulates BDNF expression in rat brain — Dokl Biol Sci 2003 (PMID 14556513)pubmed.ncbi.nlm.nih.gov
- PubMedTemporal dynamics of NGF and BDNF gene expression — J Mol Neurosci 2010 (PMID 19662538)pubmed.ncbi.nlm.nih.gov
- PubMedSemax affects immune and vascular gene expression in rat focal ischaemia — BMC Genomics 2014 (PMID 24661604)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Semax acetate (CID 155977617)pubchem.ncbi.nlm.nih.gov
- RefMHRA — Medicines and Healthcare products Regulatory Agencygov.uk
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More Semax (ACTH Fragment Peptide) articles
- What Are Glyprolines? The Pro-Gly-Pro Motif ExplainedPro-Gly-Pro is a collagen-derived tripeptide used to stabilise designed peptides. Why proline resists peptidases, and what the motif contributes to Semax and Selank.
- Semax Mechanism: Neurotrophin ExpressionSemax has been reported to upregulate BDNF and NGF expression with downstream TrkB and TrkA signalling. What the rodent studies measured and what they did not.
- Semax in the Published LiteratureAbout 231 indexed PubMed records. The mechanistic work is rodent, the clinical work largely Russian-language. How to read an unevenly distributed evidence base.
- Semax Regulatory Status: Registered Where, and Why It MattersSemax is a registered medicine in the Russian Federation and holds no MHRA, EMA or FDA authorisation. What a national registration does and does not mean.
- Semax CAS Number and Chemical IdentitySemax CAS Registry Number is 80714-61-0, PubChem CID 9811102, UNII I5FAL2585H. Identifiers for cross-referencing a certificate of analysis against the literature.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchThe History of Retatrutide (LY3437943)
- GHK-Cu (Copper Peptide)GHK-Cu Studied Effects in the Literature
- TB-500 (Thymosin β4 fragment)TB-500 Storage and Reconstitution Handling
- BPC-157 (Pentadecapeptide)BPC-157 Storage and Reconstitution Handling
- CJC-1295 & IpamorelinCJC-1295 and Ipamorelin Synergy Research
- Peptide ReferenceWhat Is HPLC Testing for Peptides?
- Bacteriostatic WaterHow Bacteriostatic Water Works (Benzyl Alcohol)
- Research & Regulatory NewsRetatrutide TRIUMPH-1: The Phase 3 Results
- GLP-1 & Incretin ScienceWhat the Data Says About Weight Regain After Stopping
- MOTS-c (Mitochondrial Peptide)MOTS-c in the Published Literature